Effects of triamcinolone acetonide injections with and without preservative.

about

Clinical Outcomes of Intravitreal Preservative-Free Triamcinolone Preparation (Triesence®) for Cystoid Macular Oedema and Inflammation in Patients with Uveitis.

P2860

Q50789266-2F666B8C-EBED-44EE-8517-4A0DAE446D61

P2860

Effects of triamcinolone acetonide injections with and without preservative.

Item

http://www.wikidata.org/entity/Q42410041

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Effects of triamcinolone acetonide injections with and without preservative.

@en

Effects of triamcinolone acetonide injections with and without preservative.

@nl

type

Item

label

Effects of triamcinolone acetonide injections with and without preservative.

@en

Effects of triamcinolone acetonide injections with and without preservative.

@nl

prefLabel

Effects of triamcinolone acetonide injections with and without preservative.

@en

Effects of triamcinolone acetonide injections with and without preservative.

@nl

P1476

Effects of triamcinolone acetonide injections with and without preservative.

@en

P2860

Intravitreal triamcinolone acetonide for cataract surgery with iris neovascularization.

Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.

Exudative macular degeneration and intravitreal triamcinolone. A pilot study.

Intravitreal triamcinolone for refractory diabetic macular edema.

Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.

Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.

Evaluation of intravitreal kenalog toxicity in humans.

Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy.

Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

Intravitreal triamcinolone acetonide: a change in a paradigm.

P304

1099-1101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1136/BJO.2007.117432

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jost B Jonas

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6129546

http://www.w3.org/2001/XMLSchema#string

P698

17709575

http://www.w3.org/2001/XMLSchema#string

P932

1954933

http://www.w3.org/2001/XMLSchema#string

Effects of triamcinolone acetonide injections with and without preservative.

about

P2860

P2860

Effects of triamcinolone acetonide injections with and without preservative.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932